This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Orexo Ab. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Michael John Sumner: Innovator in Opioid Dependence Treatment
Introduction
Michael John Sumner is an accomplished inventor based in Malvern, PA (US). He has made significant contributions to the field of addiction treatment, particularly focusing on opioid dependence. With a total of 3 patents, Sumner's work aims to improve the lives of individuals struggling with substance misuse.
Latest Patents
Sumner's latest patents include innovative methods for managing depression and alcohol consumption in subjects undergoing treatment for opioid dependence. The first patent, titled "Method of controlling depression in subjects treated for opioid dependence," outlines a step-wise interactive process that combines opioid agonist treatment with virtual cognitive behavioral therapy. This approach allows for self-treatment through a mobile medical application, providing a comprehensive solution for those experiencing depressive episodes.
The second patent, "Method of controlling alcohol consumption in subjects treated for opioid dependence," addresses the challenges faced by individuals misusing alcohol while receiving opioid treatment. Similar to his first patent, this method employs a step-wise interactive process and virtual cognitive behavioral therapy, enabling subjects to manage their alcohol consumption effectively through a self-treatment program.
Career Highlights
Michael John Sumner is currently associated with Orexo AB, a company dedicated to developing innovative treatments for addiction and mental health disorders. His work at Orexo has been instrumental in advancing therapeutic options for patients dealing with the complexities of opioid dependence.
Conclusion
Michael John Sumner's contributions to the field of addiction treatment through his patents reflect his commitment to improving patient outcomes. His innovative methods for managing depression and alcohol consumption in opioid-dependent individuals showcase the potential for technology to enhance traditional treatment approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile